Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
boulardii and LGG covers multiple mechanisms: toxin neutralization, intestinal barrier strengthening, fluid balance normalization, and immune modulation
FDA Approved: No Generic Name: Retatrutide Manufacturer: Eli Lilly and Company Intended Use: Treatment of Obesity and Overweight Retatrutide is a next-generation, triple-hormone receptor agonist currently under development for the treatment of obesity
Among SGLT2 inhibitors users, the mean age ( SD) was 65.1 11.5 years, 64.8% were men, 10.7% had a history of heart failure, 15.3% had a history of chronic kidney disease, and 29.2% had a history of ASCVD
If you notice any change in appearance, discard the medication immediately and contact your prescriber for a replacement
Fill, Pharm.D., MBA Last update: February 23, 2026 Est
US$ 23.25
US$ 20.94
US$ 24.78
US$ 22.95
US$ 20.45
US$ 20.29
US$ 23.39
